Danaher
Update in progressDHR (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services worldwide. It operates through Biotechnology, Life Sciences, and Diagnostics. Biotechnology offers tools, consumables, and services to accelerate therapeutics development and manufacturing, including cell culture and single-use systems. Life Sciences supplies analytical instruments, genomics, and lab automation. Diagnostics provides clinical instruments, reagents, software, and services for disease diagnosis. Founded 1969; headquartered in Washington, DC.
Company score
- Sentiment
- 0.63
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.26
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.23
- Governance
- 0.19
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.20
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.41
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. Rainer M. Blair
- Founded1969
- Employees58,000
- Websitewww.danaher.com
Identifiers
- ISINUS2358511028
- FIGIBBG000BH3JF8
- LEIS4BKK9OTCEWQ3YHPFM11
- CUSIP235851102
- CIK0000313616